Since CD39 catalyzes ATP degradation, the CD39 upregulation in asthma patients and in allergen-exposed epithelial cells may represent an inhibitory feedback response to excessive ATP, through which the maintenance of airway homeostasis may be possible. This evidence concerns the gene ENTPD1 and asthma.